Recursion Pharmaceuticals Inc (RXRX) Stock Price Today
Aura AI Summary
Key Stats
- $1.93BMarket Cap
- -Volume
- HealthSector
- $6.7952W High
- $2.8452W Low
- -Typical Hold Time
- $1.45BEnterprise Value
- -Div Yield
- -Trading Activity
Track Recursion Pharmaceuticals Inc (RXRX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $6.79, highlighting its annual price range. Buy and sell Recursion Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Most Recent News
Oracle's cloud growth strong but stock down 39% amid dilution and delivery issues
Oracle maintains a Buy rating from Citigroup due to strong cloud growth and a large backlog of future revenue (RPOs up 363% to $638B). Despite this, its stock has fallen 39% in the past year, trading below target price, pressured by infrastructure de...
Top chip ETF averages 14% annual return since 2001, surging 118% in past year
A leading semiconductor exchange-traded fund (ETF) has delivered an impressive average annual return of 14% since 2001. Over the last twelve months alone, the ETF surged by 118%, highlighting strong growth in the chip sector. This performance undersc...
Anthropic projects up to $30 trillion potential revenue, but experts warn it's a market size, not guaranteed income.
Anthropic has told investors its potential revenue could reach $30 trillion, roughly equal to the US GDP, but this figure represents the total addressable market, assuming it captures 100% of it. Analysts estimate Anthropic's actual revenue this year...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.